Ipsen (IPSEF) FFO


IPSEF Ipsen SA IPSEF
95 GF Score
Price $113.13
GF Value $92.81
! 7 Warning Signs
View Full Analysis

What is Ipsen FFO?

FFO (Funds from operations) only applies to REITs.

IPSEF
95GF Score
Ipsen SA IPSEF
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Ipsen (IPSEF) Overvalued in 2026?

Based on GuruFocus' analysis, Ipsen stock appears to be overvalued. The current stock price of $113.13 is trading 21.9% above its estimated GF Value™ of $92.81.

Key valuation signals for IPSEF:

  • FFO:
  • GF Value™: $92.81 vs. price of $113.13 (21.9% above fair value)
  • GF Score™: 95/100 with 7 warning signs

No single metric tells the full story. See the IPSEF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ipsen Business Description

Address 70 rue Balard, Paris, FRA, 75015
Ipsen is a global biotechnology company headquartered in France that develops and commercializes medicines across three therapeutic areas: oncology, neuroscience, and rare diseases. Ipsen was founded in 1929 as a consumer healthcare company focused on prescription-based products for digestive disorders and neurological disorders, but in February 2022, Ipsen announced the divestment of its consumer healthcare business, which accounted for only 8% of 2021 revenue. Ipsen has a large global footprint and sells more than 20 drugs in 115 countries.
95GF Score

Get the complete analysis for IPSEF

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$113.13
Price
$92.81
GF Value